Viewing Study NCT03849469


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-03-11 @ 7:35 AM
Study NCT ID: NCT03849469
Status: COMPLETED
Last Update Posted: 2023-03-30
First Post: 2019-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Sponsor: Xencor, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: XmAb22841-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View